EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer

Mingyi Nie, Tian Li, Peng Liu, Xueni Wang

Molecular Biology Reports · 2024-12 · 51 (1)

DOI: 10.1007/s11033-024-09917-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, online erschienen am 18.09.2024. Verfasst von Mingyi Nie und 3 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning, 53…. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Foundation of Guangxi Key Laboratory of Marine Drugs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer development and progression are driven by androgens, and changes in androgen metabolic pathways can lead to prostate cancer progression or remission. AKR1C2 is a member of the aldo-keto reductase superfamily and plays an important role in the metabolism of steroids and prostaglandins. Alterations in the expression and activity of AKR1C2 affect the homeostasis of active androgens, which in turn affects the progression of prostate cancer. AKR1C2 reduces the highly active dihydrotestosterone to the less active 3α-diol in the prostate, resulting in lower androgen levels. Whereas the expression of AKR1C2 is significantly reduced in prostate cancer tissues relative to normal prostate tissues, this results in a weakening of the dihydrotestosterone metabolic inactivation pathway, leading to the retention of dihydrotestosterone in the prostate cancer cells, which promotes the progress of prostate cancer. Given the critical role of AKR1C2 in prostate cancer cells, targeting AKR1C2 for the treatment of prostate cancer may be an effective strategy. It has been demonstrated that curcumin and neem leaf extract effectively inhibit prostate cancer in vitro and in vivo by modulating AKR1C2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMaleHumansHydroxysteroid DehydrogenasesAnimalsCell Line, TumorCurcuminDihydrotestosteroneGene Expression Regulation, NeoplasticAndrogens3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)

Stichwörter der Autor:innen

AKR1C2Androgen metabolismCurcuminNeem leaf extractProstate cancer

Substanzen

Hydroxysteroid DehydrogenasesCurcuminDihydrotestosteroneAndrogensAKR1C2 protein, human3-alpha-Hydroxysteroid Dehydrogenase (B-Specific)

Autor:innen und Institutionen

  • Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning, 530200, China.
  • Guangxi key laboratory of marine drugs, Institute of marine drugs, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning, 530200, China.
  • School of Basic Medical Science, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning, 530200, China.
  • Guangxi Zhuang Yao Medicine Center of Engineering and Technology, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning, 530200, China. wangxueni@gxtcmu.edu.cn.
  • Guangxi key laboratory of marine drugs, Institute of marine drugs, Guangxi University of Chinese Medicine, 13 Wuhe Road, Qingxiu District, Nanning, 530200, China. wangxueni@gxtcmu.edu.cn.

Förderung

  • Foundation of Guangxi Key Laboratory of Marine Drugs

Zitieren

APA

Nie, M., Li, T., Liu, P., & Wang, X. (2024). Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer. Molecular Biology Reports, 51(1). https://doi.org/10.1007/s11033-024-09917-4

Vancouver

Nie M, Li T, Liu P, Wang X. Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer. Molecular Biology Reports. 2024;51(1). doi:10.1007/s11033-024-09917-4

BibTeX
@article{Nie2024,
  author = {Nie, Mingyi and Li, Tian and Liu, Peng and Wang, Xueni},
  title = {Therapeutic potential of targeting AKR1C2 in the treatment of prostate cancer},
  journal = {Molecular Biology Reports},
  year = {2024},
  volume = {51},
  number = {1},
  doi = {10.1007/s11033-024-09917-4}
}
Kostenlos starten →